Norris Medicines share news, announcements and annual reports
BSE: 524414Commercial Services & SuppliesSmall Cap
Share price at the BSE close on 28 Oct 2026. Previous close ₹15.00.
28 Oct: open ₹15.00, high ₹15.00, low ₹14.35
- Under BSE's graded surveillance, stage 0, on the list for 28 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15 Cr4,400th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 0.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 58
Norris Medicines share news and announcements
394 announcements, routine notices left out, newest first. Page 3 of 8.
Nov 2023
21 Nov · Meeting
21 Nov · Meeting
18 Nov · Board meeting
15 Nov · Board meeting
Meeting on 18 Nov 2023: annual general meeting10 Nov · Results
3 Nov · Board meeting
Meeting on 10 Nov 2023: quarterly results
Aug 2023
10 Aug · Results
3 Aug · Board meeting
Meeting on 10 Aug 2023: quarterly results
Jul 2023
21 Jul · Uploading Of Statement Of Investor Complaints Report For Period Ended June 30, 2023 Through PDF Mode As There Is An Error While Uploading XBRL File On The Portal
Jun 2023
May 2023
18 May · Board meeting
Meeting on 25 May 2023: audited results
Apr 2023
Mar 2023
24 Mar · Board meeting
Feb 2023
13 Feb · Board meeting
7 Feb · Board meeting
Meeting on 13 Feb 2023: quarterly results
Jan 2023
Nov 2022
25 Nov · Results
11 Nov · Results
11 Nov · Results
7 Nov · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Oct 2022
31 Oct · Meeting
Sep 2022
29 Sep · Meeting
Aug 2022
31 Aug · Board meeting
26 Aug · Board meeting
Meeting on 31 Aug 2022: annual general meeting4 Aug · Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 1 0
May 2022
25 May · Intimation Under Regulations 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended
25 May · Board meeting
16 May · Board meeting
Meeting on 25 May 2022: audited results
Apr 2022
20 Apr · Submission Of Certificate Under Reg. 40(9) For The Period Ended March 31, 2021
11 Apr · Submission Of Certificate Under Regulation 7(3) For The Period Ended 31St March, 2022
5 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Feb 2022
13 Feb · Revision In Policy On Materiality Of Events & Its Disclosures
2 Feb · Board meeting
Meeting on 12 Feb 2022: quarterly results